Search results for "xbridge"

Take the survey and submit a guest editorial

Authentic voices. Shared expertise. A global conversation advancing the future of diagnostics.

As validated blood tests for neuronal damage reach clinical laboratories, neurofilament light chain is drawing attention everywhere from multiple sclerosis clinics to intensive care units

New portfolio aims to support biosimilar developers accelerate the path to analytical similarity and improve process economics

Join the global clinical diagnostics conversation on LinkedIn

CLINICAL24 Ambassador Tahmina Hussain discusses why education, workforce development, and professional support must evolve alongside the future of laboratory diagnostics

CLINICAL24 Ambassador Daniel Monteiro explores the pressures facing the laboratory workforce and explains why accessible education, meaningful competency assessment, and critical thinking are essential to its future

Guest editorial written by Aida Noor, Biomedical Scientist, Founder of Biomedical Science & Beyond, CLINICAL24 Ambassador

Guest editorial by Maya Carlyle, Principal AI Engineer at the National Physical Laboratory (NPL)

Guest editorial by Frank Sandulu, award-winning Biomedical Scientist and CEO, Biomed Connect

Guest Editorial by Stephanie Ibbotson, Senior Director, Strategic Marketing and Market Access, Diasorin

Acquisition advances Leica Biosystems’ end-to-end anatomic pathology ecosystem, expanding integrated solutions that help laboratories move from sample to answer with speed and confidence for the clinicians and patients who depend on them

Download this expert SelectScience guide to explore the technologies, strategies, and emerging trends helping researchers generate deeper insight, improve efficiency, and build more confident cell line development (CLD) workflows.

A new bench-top bioreactor platform with process control designed to support GMP-ready environments from 100 mL to 10 L working volume

Irena Ivanova explores the potential of artificial intelligence to strengthen laboratory quality, efficiency and access to care while preserving human oversight and compassion

A validated bioassay that worked yesterday is not guaranteed to work tomorrow, and CRO Prolytix is urging the industry to rethink what ‘validated’ really means

Guest editorial by Russ Lebovitz, MD, PhD, is CEO and Co-Founder of Amprion

As Gram-negative resistance becomes more complex, laboratories and clinicians are working together to turn susceptibility data into more targeted treatment decisions

Uncover how ALS is readying its PFAS workflows for TFA and Europe's expanding surface and groundwater rules

Delivering reduced hands-on time, more consistent results, and higher sample throughput